South Korea's AstraZeneca Vaccine Arrives in Iran

UMMATIMES - Around 700 thousand doses of the vaccine to prevent infection with the new type of corona virus (Covid-19) from AstraZeneca, which is produced in South Korea (South Korea), arrived in Iran on Tuesday (6/4).

Iranian government news agency IRNA reported that the Covid-19 vaccine from AstraZeneca, produced by SK Bioscience, had been transported via the Netherlands. So far, Iran has vaccinated 250 thousand of the 80 million total population in the Middle Eastern country.

Previously, Iran gave Covid-19 vaccinations with vaccine products made in Russia and China. At least 56,000 people have received either two doses or the complete dose of the vaccine.

Iran's health authorities approved the emergency use of the Covid-19 AstraZeneca vaccine produced in South Korea on February 18. The country has so far confirmed 1,945,964 cases of infection with the new type of corona virus, with the total deaths related to this epidemic reaching 63,332 people.

Many countries are carrying out extensive Covid-19 vaccination efforts aimed at controlling the pandemic and hopefully bringing life back to normal. Not a few are also competing to launch vaccines, including Iran, which is also trying to develop vaccine products to prevent infection with a new type of corona virus called COVIran Barakat.

At present COVIran is still in its second clinical trial phase and is receiving the necessary licenses from the Food and Drug Administration of Iran National Committee for Ethics in biomedical research. The first phase of the trial was carried out in early January.